Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
2.595
-0.075 (-2.81%)
Nov 21, 2024, 2:14 PM EST - Market open
Sutro Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 160.96 | 153.73 | 67.77 | 61.88 | 42.72 | 42.74 | Upgrade
|
| Revenue Growth (YoY) | 230.90% | 126.84% | 9.52% | 44.84% | -0.03% | 11.24% | Upgrade
|
| Cost of Revenue | 234.77 | 180.43 | 137.17 | 104.4 | 76.96 | 65.61 | Upgrade
|
| Gross Profit | -73.82 | -26.69 | -69.4 | -42.52 | -34.24 | -22.88 | Upgrade
|
| Selling, General & Admin | 56.23 | 62.58 | 59.54 | 56 | 36.82 | 32.59 | Upgrade
|
| Operating Expenses | 56.23 | 62.58 | 59.54 | 56 | 36.82 | 32.75 | Upgrade
|
| Operating Income | -130.04 | -89.28 | -128.94 | -98.52 | -71.06 | -55.62 | Upgrade
|
| Interest Expense | -26.99 | -14.17 | -2.9 | -3.2 | -2.8 | -1.3 | Upgrade
|
| Interest & Investment Income | 18.44 | 14.51 | 3.46 | 0.58 | 1.51 | 4.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -9.58 | -9.58 | -4.55 | 0.06 | -1.17 | -2.9 | Upgrade
|
| EBT Excluding Unusual Items | -148.17 | -98.52 | -132.93 | -101.08 | -73.52 | -55.74 | Upgrade
|
| Gain (Loss) on Sale of Investments | 40.03 | 9.92 | 16.23 | -4.45 | 41.5 | - | Upgrade
|
| Pretax Income | -108.14 | -88.6 | -116.7 | -105.54 | -32.03 | -55.74 | Upgrade
|
| Income Tax Expense | 15.82 | 18.19 | 2.5 | - | 0.1 | - | Upgrade
|
| Net Income | -123.95 | -106.79 | -119.2 | -105.54 | -32.13 | -55.74 | Upgrade
|
| Net Income to Common | -123.95 | -106.79 | -119.2 | -105.54 | -32.13 | -55.74 | Upgrade
|
| Shares Outstanding (Basic) | 71 | 60 | 51 | 46 | 33 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 60 | 51 | 46 | 33 | 23 | Upgrade
|
| Shares Change (YoY) | 20.70% | 18.57% | 10.02% | 41.58% | 41.88% | 298.66% | Upgrade
|
| EPS (Basic) | -1.73 | -1.78 | -2.35 | -2.29 | -0.99 | -2.43 | Upgrade
|
| EPS (Diluted) | -1.73 | -1.78 | -2.35 | -2.29 | -0.99 | -2.43 | Upgrade
|
| Free Cash Flow | -109.2 | -115.93 | -4.31 | -97 | -74.93 | -68.5 | Upgrade
|
| Free Cash Flow Per Share | -1.53 | -1.93 | -0.08 | -2.10 | -2.30 | -2.98 | Upgrade
|
| Gross Margin | -45.86% | -17.36% | -102.40% | -68.71% | -80.14% | -53.53% | Upgrade
|
| Operating Margin | -80.79% | -58.07% | -190.26% | -159.22% | -166.32% | -130.15% | Upgrade
|
| Profit Margin | -77.01% | -69.47% | -175.89% | -170.55% | -75.20% | -130.44% | Upgrade
|
| Free Cash Flow Margin | -67.85% | -75.41% | -6.36% | -156.76% | -175.39% | -160.30% | Upgrade
|
| EBITDA | -122.96 | -82.46 | -123.25 | -93.68 | -66.76 | -50.84 | Upgrade
|
| EBITDA Margin | -76.40% | -53.64% | -181.86% | -151.39% | -156.27% | -118.97% | Upgrade
|
| D&A For EBITDA | 7.08 | 6.82 | 5.69 | 4.84 | 4.3 | 4.78 | Upgrade
|
| EBIT | -130.04 | -89.28 | -128.94 | -98.52 | -71.06 | -55.62 | Upgrade
|
| EBIT Margin | -80.79% | -58.07% | -190.26% | -159.22% | -166.32% | -130.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.